FAMILIAL MEDITERRANEAN FEVER IN THE COLCHICINE ERA - THE FATE OF ONE FAMILY

被引：17
|
作者：
ZEMER, D
LIVNEH, A
PRAS, M
SOHAR, E
机构：
[1] Sheba Medical Center, Heller Institute of Medical Research
来源：
AMERICAN JOURNAL OF MEDICAL GENETICS | 1993年 / 45卷 / 03期
关键词：
COLCHICINE; FAMILIAL MEDITERRANEAN FEVER; AMYLOIDOSIS;
D O I：
10.1002/ajmg.1320450311
中图分类号：
Q3 [遗传学];
学科分类号：
071007 ; 090102 ;
摘要：
In order to demonstrate the effect of prophylactic colchicine treatment on the natural history of familial Mediterranean fever (FMF), a family is presented with 6 out of 9 siblings affected by FMF. Each patient represents a different stage of the amyloidotic kidney disease of FMF and the effect of continuous colchicine treatment on its course. Considered together, the members of this family present an almost complete clinical, genetic, and behavioral picture of the disease.
引用
收藏
页码：340 / 344
页数：5
相关论文
共 50 条
  • [1] Colchicine treatment in children with familial Mediterranean fever
    Özkaya, N
    Yalçinkaya, F
    CLINICAL RHEUMATOLOGY, 2003, 22 (4-5) : 314 - 317
  • [2] Treatment of Familial Mediterranean Fever: Colchicine and Beyond
    Gul, Ahmet
    ISRAEL MEDICAL ASSOCIATION JOURNAL, 2014, 16 (05): : 281 - 284
  • [3] Colchicine treatment in children with familial Mediterranean fever
    N. Özkaya
    F. Yalçınkaya
    Clinical Rheumatology, 2003, 22 : 314 - 317
  • [4] Different pharmaceutical preparations of colchicine for Familial Mediterranean Fever: are they the same?
    Emmungil, Hakan
    Ilgen, Ufuk
    Turan, Sezin
    Yaman, Samet
    Kucuksahin, Orhan
    RHEUMATOLOGY INTERNATIONAL, 2020, 40 (01) : 129 - 135
  • [5] Approach to the patients with inadequate response to colchicine in familial Mediterranean fever
    Gul, Ahmet
    BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 2016, 30 (02): : 296 - 303
  • [6] Familial Mediterranean Fever Risk Factors, Causes of Death, and Prognosis in the Colchicine Era
    Akar, Servet
    Yuksel, Feride
    Tunca, Mehmet
    Soysal, Ozgul
    Solmaz, Dilek
    Gerdan, Vedat
    Celik, Ali
    Sen, Gercek
    Onen, Fatos
    Akkoc, Nurullah
    MEDICINE, 2012, 91 (03) : 131 - 136
  • [7] Current trends in colchicine treatment in familial Mediterranean fever
    La Regina, M.
    Ben-Chetrit, E.
    Gasparyan, A. Y.
    Livneh, A.
    Ozdogan, H.
    Manna, R.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2013, 31 (03) : S41 - S46
  • [8] COLCHICINE CONCENTRATION IN LEUKOCYTES OF PATIENTS WITH FAMILIAL MEDITERRANEAN FEVER
    CHAPPEY, O
    NIEL, E
    DERVICHIAN, M
    WAUTIER, JL
    SCHERRMANN, JM
    CATTAN, D
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1994, 38 (01) : 87 - 89
  • [9] Early predictors of colchicine resistance in familial Mediterranean fever
    Mosa, Doaa Mosad
    Shokry, Doaa
    Ahmed, Dina B.
    Sobh, Ali
    MODERN RHEUMATOLOGY, 2023, 33 (04) : 830 - 835
  • [10] Diagnostic validity of colchicine in patients with Familial Mediterranean fever
    Ozaltin, Fatih
    Bilginer, Yelda
    Gulhan, Bora
    Bajin, Inci
    Erdogan, Ozlem
    Hayran, Mutlu
    Yilmaz, Engin
    Ozen, Seza
    CLINICAL RHEUMATOLOGY, 2014, 33 (07) : 969 - 974
12345